These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16870073)

  • 21. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
    Leibson CL; Barbaresi WJ; Ransom J; Colligan RC; Kemner J; Weaver AL; Katusic SK
    Ambul Pediatr; 2006; 6(1):45-53. PubMed ID: 16443183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.
    Babcock T; Ornstein CS
    Postgrad Med; 2009 May; 121(3):73-82. PubMed ID: 19491543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ED visits by older adults for ambulatory care-sensitive and supply-sensitive conditions.
    Carter MW; Datti B; Winters JM
    Am J Emerg Med; 2006 Jul; 24(4):428-34. PubMed ID: 16787800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults.
    Asherson P
    Expert Rev Neurother; 2005 Jul; 5(4):525-39. PubMed ID: 16026236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ambulatory medical care utilization estimates for 2005.
    Burt CW; McCaig LF; Rechtsteiner EA
    Adv Data; 2007 Jun; (388):1-15. PubMed ID: 17784725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients.
    Nylander L; Holmqvist M; Gustafson L; Gillberg C
    Nord J Psychiatry; 2009; 63(1):64-71. PubMed ID: 18991159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.
    Gerhard T; Winterstein AG; Olfson M; Huang C; Saidi A; Crystal S
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):457-64. PubMed ID: 20232490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
    Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
    Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors, clinical characteristics, and outcome of conduct disorder in girls with attention-deficit/hyperactivity disorder: a longitudinal study.
    Monuteaux MC; Faraone SV; Michelle Gross L; Biederman J
    Psychol Med; 2007 Dec; 37(12):1731-41. PubMed ID: 17451627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.
    Barsky AJ; Orav EJ; Bates DW
    Arch Gen Psychiatry; 2005 Aug; 62(8):903-10. PubMed ID: 16061768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identified attention-deficit/hyperactivity disorder and medically attended, nonfatal injuries: US school-age children, 1997-2002.
    Pastor PN; Reuben CA
    Ambul Pediatr; 2006; 6(1):38-44. PubMed ID: 16443182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between patient age and duration of physician visit in ambulatory setting: does one size fit all?
    Lo A; Ryder K; Shorr RI
    J Am Geriatr Soc; 2005 Jul; 53(7):1162-7. PubMed ID: 16108934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity study of ADHD: applying association rule mining (ARM) to National Health Insurance Database of Taiwan.
    Tai YM; Chiu HW
    Int J Med Inform; 2009 Dec; 78(12):e75-83. PubMed ID: 19853501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005.
    Pallin DJ; Espinola JA; Leung DY; Hooper DC; Camargo CA
    Clin Infect Dis; 2009 Sep; 49(6):901-7. PubMed ID: 19663690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of a special consultation for attention deficit/hyperactivity disorder in adults].
    Davids E; Krause DA; Specka M; Gastpar M
    Gesundheitswesen; 2004 Jul; 66(7):416-22. PubMed ID: 15314733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
    Wilens TE; Adler LA; Weiss MD; Michelson D; Ramsey JL; Moore RJ; Renard D; Brady KT; Trzepacz PT; Schuh LM; Ahrbecker LM; Levine LR;
    Drug Alcohol Depend; 2008 Jul; 96(1-2):145-54. PubMed ID: 18403134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.